低血糖症（Hypoglycemia）：グローバル臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hypoglycemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hypoglycemia 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Hypoglycemia Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Hypoglycemia 32
Oct 17, 2013: Xeris Pharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of its Investigational Soluble Glucagon Formulation 32
Oct 16, 2012: DiaMedica Announces That Co-administration Of DM-199 With Insulin Enhances Insulin’s Glucose Lowering Activity 32
Apr 20, 2012: Novo Nordisk Announces Publication Of Two Phase III Studies On Ultra-long-acting Insulin Degludec In The Lancet 33
Jun 27, 2011: LCT Enrols First Patients In Phase II DIABECELL Argentina Trial 33
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
XERIS Pharmaceuticals, Inc. 35
Clinical Trial Overview of XERIS Pharmaceuticals, Inc. 35
Sanofi 36
Clinical Trial Overview of Sanofi 36
Novo A/S 37
Clinical Trial Overview of Novo A/S 37
Hypo-Safe A/S 38
Clinical Trial Overview of Hypo-Safe A/S 38
AMG Medical Inc. 39
Clinical Trial Overview of AMG Medical Inc. 39
Covidien plc 40
Clinical Trial Overview of Covidien plc 40
Bayhill Therapeutics, Inc. 41
Clinical Trial Overview of Bayhill Therapeutics, Inc. 41
AstraZeneca PLC 42
Clinical Trial Overview of AstraZeneca PLC 42
Clinical Trial Overview of Top Institutes / Government 43
University of Minnesota 43
Clinical Trial Overview of University of Minnesota 43
Yale University 44
Clinical Trial Overview of Yale University 44
Academic Medical Center 45
Clinical Trial Overview of Academic Medical Center 45
Vanderbilt University 46
Clinical Trial Overview of Vanderbilt University 46
Hillerod Hospital 47
Clinical Trial Overview of Hillerod Hospital 47
The University of Auckland 48
Clinical Trial Overview of The University of Auckland 48
Johns Hopkins University 49
Clinical Trial Overview of Johns Hopkins University 49
The Sheba Medical Center 50
Clinical Trial Overview of The Sheba Medical Center 50
Lund University 51
Clinical Trial Overview of Lund University 51
University of Virginia 52
Clinical Trial Overview of University of Virginia 52
Five Key Clinical Profiles 53
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81